Your Article Summary
See Latest ArticlesNonresponse to pre-operative chemotherapy does not preclude long-term survival after liver resection in patients with colorectal liver metastases
Surgery, 06/29/09
Neumann UP et al. – Study reports that liver resection offers a long-term survival benefit for patients with colorectal liver metastases (CRM), even when tumor growth proceeds during pre-operative chemotherapy.
Methods- Aim was to identify risk factors for poor outcome in pts with pre-operative chemotherapy of CRM
- 160 pts analyzed; 3 groups of patients were identified:
- 44 pts (27.5%) had a tumor response
- 20 (12.5%) showed stable disease, and
- 96 (60%) pts had tumor progression while on chemotherapy
- Median f/u was 2.4 yrs; all available clinicopathologic variables possibly associated with outcome were evaluated
- Survival was 88%, 53%, and 37% at 1, 3, and 5 yrs
- Factors associated with poor outcome:
- Noncurative resection
- Carcinoembryonic antigen levels >200 ng/ml
- Tumor grading
- Size of the largest tumor >5 cm, and
- Number of metastases
- Multivariate analysis: tumor free margin and tumor grading correlated with the outcome
- Tumor progression while on chemotherapy had no influence on the long-term survival
Related Articles
Association of IGF1 and IGFBP3 polymorphisms with colorectal polyps and colorectal cancer risk
Cancer Causes and Control, 10/02/09
Relevance Score: 96%
Colorectal cancer incidence and postmenopausal hormone use by type, recency, and duration in cancer prevention study II
Cancer Epidemiology, Biomarkers & Prevention, 10/28/09
Relevance Score: 93%
P73 expression and its clinical significance in colorectal cancer
Colorectal Disease, 10/19/09
Relevance Score: 93%
Visceral Fat Volume and the Prevalence of Colorectal Adenoma
American Journal of Epidemiology, 11/19/09
Relevance Score: 92%
Aspirin as Colorectal Cancer Adjuvant Therapy
Gastroenterology, 10/05/09
Relevance Score: 91%
Today in Colorectal Cancer/Polyps...keeping you current
Receive free subspecialty "5-minute updates" via email
EORTC Elderly Task Force experts opinion for the treatment of colon cancer in older patients
Cancer Treatment Reviews, 12/04/09
Absolute benefits of medical therapies in phase III clinical trials for breast and colorectal cancer
Annals of Oncology, 12/04/09
Bevacizumab combined with chemotherapy for patients with advanced colorectal cancer: a systematic review
Annals of Oncology, 12/04/09
Today in Pharmacology/Therapy...keeping you current
Receive free subspecialty "5-minute updates" via email
Management of patients with advanced bladder cancer following major response to systemic chemotherapy
Expert Review of Anticancer Therapy, 12/04/09
ML17032 trial: capecitabine/cisplatin versus 5-fluorouracil/cisplatin as first-line therapy in advanced gastric cancer
Expert Review of Anticancer Therapy, 12/04/09
Degarelix 240/80 mg: a new treatment option for patients with advanced prostate cancer
Expert Review of Anticancer Therapy, 12/04/09